ANVS vs BLK · $80.4M cap vs P/E 27, rev $24.22B
Annovis Bio Inc (ANVS) versus BlackRock Inc (BLK) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
BlackRock Inc (BLK) is a asset management company listed on NYSE. It is led by Larry Fink.
Latest reported ANVS revenue for 2024-12-31 was $0. Net income was -$24.6M. ANVS currently screens at market cap $80.4M.
Latest reported BLK revenue for 2025-12-31 was $24.22B. Net income was $5.55B. Revenue was up 89.3% from 2024-12-31 to 2025-12-31. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
ANVS currently screens at market cap $80.4M. BLK currently screens at market cap $172.19B and trailing P/E 26.6.
Not investment advice. Open the ANVS and BLK stock pages for the full models.
Not investment advice.